Prior transfusion of umbilical cord mesenchymal stem cells can effectively alleviate symptoms of motion sickness in mice through interleukin 10 secretion

Figure 2 AS101 inhibits spontaneous interleukin-10 secretion by umbilical cord-derived mesenchymal stem cells. A: Secreted interleukin-10 (IL-10) levels in the supernatant under exposure to different AS101 concentrations, as measured by enzyme-linked immunosorbent assay. The IL-10 level decreased with 1.5-3.0 μg/mL of AS101; B and C: Flow cytometry analysis of the viability of umbilical cord-derived mesenchymal stem cells (UC-MSCs) after co-culture with AS101. There was no significant difference in the proportion of UC-MSCs according to AS101 concentration. IL-10: Interleukin-10.